These grants provide up to £30,000 over 1-2 years for consumables, to support Clinical Lecturers who are looking to develop and strengthen their research careers.
Round 20 is now closed. The panel will convene in December.
These grants provide up to £30,000 over 1-2 years for consumables, to support Clinical Lecturers who are looking to develop and strengthen their research careers.
Round 20 is now closed. The panel will convene in December.
Starter Grants for Clinical Lecturers offer funding of up to £30,000 to cover the cost of research consumables. The grants allow research-active Clinical Lecturers to gather data to strengthen their bids for longer-term fellowships and funding.
To read case studies from previous and current Starter Grant holders, click here.
About the scheme
This scheme was launched in October 2008 as a partnership between the Academy and the Wellcome Trust, current funders of the scheme are the Wellcome Trust, British Heart Foundation (2011), Arthritis Research UK (2012), Medical Research Council (2013), Diabetes UK (2016) and the British Thoracic Society (through the Helen and Andrew Douglas bequest for the use of research into tuberculosis control; 2018).
The grants provide modest ‘starter’ funds to enable research active Clinical Lecturers to pursue their research work. Clinical Lecturer posts provide a salary but often do not come with the funding to support the costs of the research. This scheme was designed to help bridge this gap by providing Clinical Lecturers with access to modest research funds for up to two years. It gives them experience of preparing a research grant application and helps them establish their research portfolios by providing funding for research consumables.
So far we have supported approximately 413 Clinical Lecturers through 18 rounds of funding, with grants totalling nearly £12 million. In 2016, the Academy and the Wellcome Trust carried out a review of the scheme, which you can download from the right hand side of this page.
In December 2013, we launched the Winter Science Meeting, an annual event Starter Grant awardees are invited to. For more information please visit the main Winter Science Meeting page.
The grants are intended as start-up funding and as such are not intended for applicants who have already obtained substantial funding through, for example, Clinician Scientist Fellowships, New Investigator Awards or large project grants.
All eligible applicants must:
1. Have a PhD or MD.
2. Hold a medical, dental or veterinary undergraduate degree and be registered with the General Medical Council, General Dental Council or Royal College of Veterinary Surgeons.
3. Hold a clinical contract.
If you are a clinician in human or dental medicine, you must also:
1. Be a research-active Clinical Lecturer
2. Hold an NTN or NTN(A)
3. Be within higher specialty training.
4. Have undertaken a substantial period of research equivalent to a PhD or research MD, if you have qualified abroad with an MD.
5. Note the following eligibility criteria relating to the timing of your CCT:
Senior Clinical Lecturers and Clinical Psychologists are not eligible for this scheme.
If you are a clinician in veterinary medicine, you must be either:
1. A research-active Veterinary Specialist in Training (Resident/Senior Clinical Training Scholar) within an approved Specialist Training Programme with secured and protected research time throughout the proposed project.
2. A research-active Veterinary Clinician or Veterinary Pathologist with Veterinary Specialist Board qualification or eligibility and within the 3 year (probationary) period of your first University appointment and with secured and protected research time throughout the proposed project. If your position is that of a Senior Lecturer but are still within the three year probationary period then you are still eligible for this scheme.
Please contact the grants team if you have any other queries about the scheme on 020 3176 230, or email us at email@example.com
This scheme is targeted at those who are in the earlier years of their Clinical Lecturer appointment. You should not already have obtained substantial funding from other sources, for example a Clinician Scientist Fellowship, New Investigator Award or large project grant.
The maximum grant available is £30,000. This can be spread over one to two years to contribute towards directly incurred research costs such as consumables and equipment.
Grants cannot be used to pay for your personal salary costs or to employ research assistants, PhD students or postdoctoral staff.
The Academy recognises the challenges clinicians face when managing a clinical and a research career with family and caring commitments. During the review process, prior career breaks will be taken into account when evaluating a candidate’s research output and progress. If you are successful, you will be able to apply for a no-cost extension to your grant to account for periods of absence or delays in your project during your award. For an example of the success such Starter Grant holders can achieve, please click here.
Successful applicants cannot reapply. Unsuccessful applicants are limited to one resubmission.
Like all UK post-doctoral clinicians, Starter Grant holders are eligible for the Academy's one-to-one mentoring scheme and are encouraged to contact the Office regarding this.
The current members of the selection panel are:
Professor Wiebke Arlt FMedSci (chair), University of Birmingham
Professor David Burn FMedSci, Newcastle University
Professor Edwin Chilvers FMedSci, University of Cambridge
Professor Carol Dezateux CBE FMedSci, Queen Mary University of London
Professor David Edwards FMedSci, King's College London
Professor Stephen Franks FMedSci, Imperial College London
Professor Iain McInnes FRSE FMedSci, University of Glasgow
Professor David Neal CBE FMedSci, University of Oxford
Professor David Newby FRSE FMedSci, University of Edinburgh
Applicants should not approach Panel members to discuss their application. All queries should be directed to the Panel secretariat on firstname.lastname@example.org.
All Starter Grant Holders are required to report via Researchfish annually by the end of March each year throughout their grant and for three years after the completion of their award. Click here for full reporting instructions.
A report of Starter Grant Holders' research outcomes submitted to us during our first Researchfish submission window in 2016 is available for download on the right hand side of this page.
You will also need to submit (via email to email@example.com) a Final Expenditure Report within 3 months of the end of your grant in addition to submitting Researchfish data. You can download the final expenditure form from the right hand side of this page.
Hussein Al-Mossawi, University of Oxford, Single cell transcriptomic analysis of the T cell compartment in psoriatic arthritis
Nishkantha Arulkumaran, University College London, A New Antibacterial Route to Selectively Rupture Bacterial Membranes
Vian Azzu, University of Cambridge, The role of monocyte metabolism and signalling in non-alcoholic fatty liver disease
Mohammed Zaeem Cader, University of Cambridge, The role of FAMIN in controlling macrophage lipid biology and restricting inflammation
Johnathan Cooper-Knock, University of Sheffield, Characterisation of a novel genetic variant discovered by exome sequencing in familial amyotrophic lateral sclerosis
Felicity Fitzgerald, University College London, Carriage of antimicrobial resistant bacteria in children in Zimbabwe
Pankaj Garg, University of Sheffield, Whole heart, four-dimensional flow magnetic resonance imaging for accurate assessment of right and left heart flow haemodynamics
Alexandra Gilbert, University of Leeds, Developing predictive models of pelvic radiotherapy-related toxicity using patient reported outcomes
Rachel Guest, University of Edinburgh, Identifying novel genetic drivers of cholangiocarcinoma in primary sclerosing cholangitis
Melanie Hezzell, University of Bristol, Does surgical implantation of a novel bioprosthetic valved conduit in the right ventricular outflow tract affect right ventricular structure and function in healthy pigs?
Laura Jardine, Newcastle University, The evolution of clonal haematopoiesis in individuals with heterozygous GATA2 mutation
Simon Johnston, University of Nottingham, Effect of FoxA1 mutations on the transcriptional response to tamoxifen in lobular breast cancer
Paul Maciocia, University College London, A simple and non-genotoxic method to produce 'off the shelf' allogeneic chimeric antigen receptor T-cells
Barry Main, University of Bristol, Exploring strategies for implementing core information sets for informed consent to surgery for head and neck cancer: operationalising Montgomery
Thomas McKerrell, University of Cambridge, Single cell transcriptome profiling of mutant haematopoietic stem and progenitor cells (HSPCs) in patients with myeloproliferative neoplasms (MPN) enrolled in the TAMARIN clinical trial
Charlotte Pawlyn, Institute of Cancer Research, Developing 3D ex vivo models to study novel therapies targeting high-risk myeloma.
Michele Petruzzelli, University of Cambridge, Implicating the metabolic burden of anti-cancer immunity in cancer cachexia
Anvesha Singh, University of Leicester, Role of elastin in aortic remodelling in bicuspid and tricuspid aortic stenosis- a pilot metabolomics and MRI study
Carol Sinnott, University of Cambridge, Operational failures in general practice: An observational study of what general practitioners do and what gets in the way of doing it
Colin Steele, University of Glasgow, Characterising CXCR2 expressing neutrophils in colorectal liver metastases
Lisa Story, King's College London, MRI assessment of the cervix in non-pregnant women at risk of premature birth; a useful tool for assessment of cervical incompetence? A pilot study
Mark Thomas, University of Birmingham, Impact of GPVI inhibition on fibrin-mediated platelet responses
Thomas Treibel, University College London, Comprehensive Myocardial Phenotyping in Aortic Stenosis
Timothy Walker, University of Oxford, Whole-genome sequencing M. tuberculosis in a remote, high burden setting
Yin Wu, University College London, Investigating the immune regulation of non-small cell lung cancer by gamma-delta T-cells
Kenny Yu, University of Manchester, Dissecting the heterogeneity of neuroinflammation in low grade and transforming astrocytomas using single cell RNAseq
Sarah Alderson, University of Leeds, An interrupted time series analysis of the Campaign to Reduce Opioid Prescribing
Marc Bailey, University of Leeds, Imaging pathological vascular remodelling in abdominal aortic aneurysm using [18F]Fluorothymidine
Harry Bulstrode, University of Cambridge, Studying gliomagenesis using defined mutations in primary human brain cells
Faye Cooles, Newcastle University, Early RA patient stratification by interferon gene signature – towards optimising clinical outcomes
Rebecca Hill, Newcastle University, Characterising and understanding the mutational landscape of relapsed medulloblastoma
Sarah Howles, University of Oxford, The role of High Mobility Group Nucleosomal Binding Protein 1 in the regulation of urinary calcium excretion.
Aadil Khan, Institute of Cancer Research, Elucidating the drivers of radiation fibrosis in normal tissues: a translational study of neoadjuvant breast radiotherapy and free flap reconstruction
Simon Lambden, University of Cambridge, The role of the pulmonary endothelial HIF isoforms in regulating systemic vascular function
Eileen Parkes, Queen’s University of Belfast, Investigating the immune response to neoadjuvant chemotherapy in breast cancer
Lucia Possamai, Imperial College London, Interactions between Kupffer cells and monocytes in sterile liver inflammation
Paul Ryan, Queen Mary University of London, Investigating phenotypic and functional heterogeneity in γδ T cells
Marietta Stadler, King’s College London, Exploring the barriers to a safe diabetes control in people with type 1 diabetes and eating disorders through better understanding of the psychological and physiological triggers leading to insulin omission
Victoria Stoll, University of Birmingham, Advanced Cardiovascular Magnetic Resonance Techniques to Identify Novel Imaging Biomarkers of Disease Progression and Therapeutic Response in Congenital Heart Disease
Kate Tatham, Imperial College London, The Role of the Lungs in Monocyte Dysfunction in Sepsis
Sofia Theodoropoulou, University of Bristol, The role of mast cells in the pathophysiology of age-related macular degeneration
Kate Walker, University of Nottingham, Childbirth experience questionnaire 2: validating its use in the United Kingdom
Steven Williams, King’s College London, A combined optical and electrogram mapping system to determine the impact of atrial remodelling on electrogram morphology
Tom Wingfield, University of Liverpool, END-TB: enhancing TB control by mitigating catastrophic costs of TB-affected households
Paolo Biancheri, University of East Anglia, Proteolytic degradation of anti-tumour necrosis factor (TNF)-alpha and anti-integrin agents: correlation with response to treatment in inflammatory bowel disease (IBD)
Delanjathan Devakumar, University College London, Long-term effects of the Indian Ocean tsunami in Sri Lankan adolescents
Jessica Eccles, University of Sussex, Applying leading-edge multimodal neuroimaging and neural connectivity tools to characterise brain mechanisms that link joint hypermobility to anxiety
Amy Foulkes, University of Manchester, STRATOSPHERE: STRATification Of Systemic Psoriasis THERapiEs
Alex Gordon-Weeks, University of Oxford, Fibroblast Growth Factor Receptor Inhibition for Vascular Normalisation and Chemosensitisation
Adam Handel, University of Oxford, Identifying pathogenic T-cell clones in autoimmune demyelinating disease using single cell sequencing
George Harston, University of Oxford, 3D pH-weighted Imaging in Acute Ischaemic Stroke
Jennifer Haworth, University of Bristol, Mechanisms of oral Streptococcus-induced platelet activation
James Hunter, University of Oxford, The effect of Normothermic machine perfusion of kidneys on mitochondrial function
Ivan Koychev, University of Oxford, Indoor and outdoor spatial navigation as a potential biomarker of preclinical Alzheimer's Disease
Oliver Lyons, King's College London, Endothelial patterning in venous valve development
Angus Macleod, University of Aberdeen, Individual-patient-data meta-analysis of prognostic studies in Parkinson's disease
Filipe Martins, University of Cambridge, PTEN expression as a biomarker for targeted therapies in high-grade serous ovarian cancer (HGSOC)
Georgios Oikonomou, University of Liverpool, Using genomics to prevent lameness-causing foot lesions in dairy cattle
Meghan Perry, University of Edinburgh, The use of metagenomics of hospital sewage as an AMR surveillance tool
Ricardo Petraco, Imperial College London, Real-time derivation of coronary pressure-flow slopes and development of novel, stenosis-specific and flow-independent parameters of stenosis severity: towards the application of invasive physiology in unstable haemodynamic conditions
Owen Pickrell, Swansea University, Using natural language processing software to enrich routinely collected electronic data for epilepsy research.
Lynne Sykes, Imperial College London, The interaction between gut microbiota, the systemic immune response and the risk of preterm labour
Karin Tuschl, University College London, Dissecting the mechanisms of manganese dyshomeostasis in disorders of manganese transport
Emma Wall, University College London, Identifying determinants of poor outcome in adult Streptococcus pneumoniae meningitis by transcriptional profiling
Michelle Williams, University of Edinburgh, Combined magnetic resonance coronary angiography and positron emission tomography in patients with coronary artery disease
Tim Williams, University of Cambridge, The role and utility of urinary exosomes in individuals with renal and urinary tract disorders
Kanmin Xue, University of Oxford, Enhancement of dual vector gene therapy for Stargardt disease through
James Alix, University of Sheffield, Developing in vivo Raman Spectroscopy for neuromuscular disease.
Rahul Bhatnagar, University of Bristol, The Semi-rigid Pleuroscopy In Routine Pleural Infection (SPIRIT) Trial
Adam Brown, University of Cambridge, Integration of anatomical imaging and biomechanics for the prediction of coronary plaque growth and rupture
Manil Chouhan, University College London (UCL), Hameodynamic Assessment of Beta-Blocker Therapy for Portal Hypertension using MRI
Thomas Darton, University of Sheffield, Investigating the effects of environmental exposure to fluoroquinolone-resistant Enterobacteriaceae on the gastrointestinal microbiota of children in Nepal
Antonio de Marvao, Imperial College London, Left ventricular hypertrophy in West Africans: discovery of genetic and environmental determinants using 3D imaging-genetics
Charlotte Elder, University of Sheffield, The pharmacokinetic evaluation of a novel non-invasive Short Synacthen Test in Children
David Eyre, University of Oxford, Complete bacterial genome sequencing and mathematical modelling to control healthcare-associated infection
Montserrat Fuste, King's College London, Identifying gene expression and neuroimaging markers for postpartum psychosis
Sherif Gonem, University of Leicester, Effect of environmental exposures on asthma symptoms, lung function and airway inflammation
Sara Hillman, University College London (UCL), An integrated multi-omic analysis of human T-regulatory cells and their role in pregnancies affected by pre-eclampsia
Rachel Jennings, University of Manchester, Molecular dissection of the transcriptome regulating differentiation from the early human embryonic pancreas.
Dan Jones, Queen Mary, University of London, The investigation of the effect of inorganic nitrite/nitrate on contrast induced nephropathy (CIN) after percutaneous coronary intervention (PCI).
Alasdair Jubb, University of Cambridge, Quantifying glucocorticoid induced chromatin reorganisation and genomic responses in human monocytes
Yee-Haur Mah, St George's, University of London, Unified high-dimensional modelling of chronic and acute injury in stroke
Benedict Michael, University of Liverpool, Identifying adjunctive therapy targets to mitigate leucocyte infiltration in herpes simplex encephalitis
Samiul Mostafa, University of Oxford, Determining optimal cardiovascular risk factor levels for individuals with type 2 diabetes mellitus (T2DM)
Amara Nwosu, University of Liverpool, The study of hydration status and complex symptoms in advanced cancer using bioelectrical impedance vector analysis (BIVA): a multi-site longitudinal cross-sectional mixed-methods study
Aghogho Odudu, University of Manchester, Oxygenation and perfusion imaging as a novel biomarker of disease progression in diabetic kidney disease
Rashmi Patel, King's College London, Symptom dimensions in first episode psychosis: predicting clinical outcomes using natural language processing
Gary Reynolds, Newcastle University, Genomic analysis of immune populations in giant cell arteritis
Aidan Rose, University of Dundee, Investigating Pro-oncogenic Activin Driven Proliferation and Clonagenicity in Human Cutaneous Squamous Cell Carcinoma
Alexander Rothman, University of Sheffield, Inhibition of SMURF1 for the treatment of pulmonary arterial hypertension
William Sedley, Newcastle University, Sensory precision in the causation and treatment of tinnitus
Maisa Seppala, King's College London, Odontomes as prognostic markers for disrupted WNT signalling
Markus Sikkel, Imperial College London, Enhancing the Therapeutic Index of Anti-arrhythmic Agents In Ischaemia through use of Hypoxia Activated Pro-drugs
Nicole Stoesser, University of Oxford, Genomic epidemiology of carbapenem resistance gene transmission amongst Enterobacteriacaeae in hospital drainage reservoirs
Peter Swoboda, University of Leeds, Assessment of the cardiovascular consequences of enforced abstinence from exercise
Rhys Thomas, Cardiff University, The neuronal glucose transporter in genetic generalised epilepsy
Naomi Walker, London School of Hygiene and Tropical Medicine, Matrix Degradation Products for TB diagnosis & prediction of TBImmune reconstitution inflammatory syndrome (IRIS)
Arash Yavari, University of Oxford, Defining the role of AMP-activated protein kinase signalling in the pathogenesis of atrial arrhythmia
Dr Sara Ajina, University of Oxford, Neural effects of rehabilitation following visual cortex damage
Dr Robert Aldridge, UCL, Public Health Informatics in the era of big data: estimating future burden of disease in England using electronic health records
Mr James Chan, University of Oxford, Upregulation of alarmins to accelerate fracture repair in normal and osteoporotic bone
Dr Andrew Douglas, University of Southampton, Therapeutic epigenetic manipulation of C9orf72 for amyotrophic lateral sclerosis and frontotemporal dementia
Dr Louis Grandjean, UCL, The Genomics of Multidrug-Resistant Tuberculosis Transmission
Dr Gordon Hutchins, University of Leeds, Towards an understanding of molecular heterogeneity in gastric cancer
Mr Farhad Iranpour Boroujeni, Imperial College London, Computer assisted patellofemoral joint surgery: Application of a novel technique for assessing dynamic patellar tracking and contact patterns in patellofemoral instability
Dr Kerri Jane Kinghorn, King's College London, Dissecting the mechanisms of pathogenesis of TBK1 mutations using ALS Drosophila models
Dr Helena Lee, University of Southampton, Oral Dopamine Replacement in the Developing Albino Retina - A Proof of Concept Study
Dr Stephen McAdoo, Imperial College London, Defining the role of SYK in the pathogenesis of experimental and clinical glomerulonephritis
Dr Roly Megaw, University of Edinburgh, In vivo correction of a human mutation in a mouse model of retinitis pigmentosa
Dr Christopher Moxon, University of Liverpool, Investigating sequestration driven pathology in cerebral malaria in vitro and post-mortem using transcriptomics
Dr Hani Nazzal, University of Leeds, Decellularisation of dental pulp for use as a scaffold in regenerative endodontics
Dr Elisabeth Rounis, University of Oxford, The neural correlates of affordance during grasp
Dr Adam Sharp, Institute of Cancer Research, Co-regulatory proteins of the androgen receptor and androgen receptor splice variants: A novel therapeutic strategy for the treatment of castration-resistant prostate cancer
Dr James Tomlinson, Imperial College London, Gene expression profiling of the proximal tubule in kidney fibrosis
The scheme is generously supported by the Wellcome Trust, Medical Research Council, British Heart Foundation, Arthritis Research UK, Royal College of Physicians and Diabetes UK.
The scheme is generously supported by the Wellcome Trust, Medical Research Council, British Heart Foundation, Arthritis Research UK, Diabetes UK and British Thoracic Society (through the Helen and Andrew Douglas bequest).
Tel: 020 3141 3221View staff bio
Tel: 020 3141 3235View staff bio